Panbela Therapeutics organizacji ROCE
Jaka jest wartość ROCE organizacji Panbela Therapeutics?
Wartość ROCE organizacji Panbela Therapeutics Inc. to -1,359.79%
Jaka jest definicja ROCE?
Zwrot z zaangażowanego kapitału Return on capital employed (ROCE) to wskaźnik finansowy, który mierzy zyskowność przedsiębiorstwa i efektywność, z jaką wykorzystywany jest jego kapitał.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE firm w Health Care sektor na NASDAQ w porównaniu do Panbela Therapeutics
Czym się zajmuję organizacja Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Firmy z roce podobne do Panbela Therapeutics
- Wartość ROCE organizacji Millennial Precious Metals Corp to -1,485.19%
- Wartość ROCE organizacji Oragenics Inc to -1,468.71%
- Wartość ROCE organizacji Hemp Naturals to -1,452.04%
- Wartość ROCE organizacji Advantagewon Oil to -1,446.04%
- Wartość ROCE organizacji Paringa Resources to -1,393.41%
- Wartość ROCE organizacji Graycliff Exploration to -1,374.81%
- Wartość ROCE organizacji Panbela Therapeutics to -1,359.79%
- Wartość ROCE organizacji U.S. Lithium to -1,313.60%
- Wartość ROCE organizacji Ucommune International Ltd to -1,285.37%
- Wartość ROCE organizacji Kopin to -1,279.14%
- Wartość ROCE organizacji 22nd Century Inc to -1,242.47%
- Wartość ROCE organizacji Imagin Medical Inc to -1,230.40%
- Wartość ROCE organizacji Aravive Inc to -1,217.82%